U.S. federal trademark · Serial No. 88730272
research and development services in the field of pharmaceuticals
pharmaceutical preparations for the treatment of neurodegenerative diseases, cancer, HIV, hematopoietic disease and disorders, blood disorders, cardiovascular diseases and disorders, genetic diseases and disorders, liver diseases and disorders, infectious diseases, immune system related diseases and disorders, metabolic diseases and disorders, kidney diseases and disorders, and reproductive diseases and disorders; pharmaceutical preparations comprised of small molecules in the nature of organic compounds that target RNA for use in medical treatments via the induction or inhibition of gene expression; pharmaceutical preparations that contain RNA-targeting small molecule therapeutics for the treatment of neurodegenerative diseases, cancer, HIV, hematopoietic disease and disorders, blood disorders, cardiovascular diseases and disorders, genetic diseases and disorders, liver diseases and disorders, infectious diseases, immune system related diseases and disorders, metabolic diseases and disorders, kidney diseases and disorders, and reproductive diseases and disorders
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.